Specific knock-down of GAD67 in the striatum using naked small interfering RNAs

Journal of Biotechnology

Volumn 142, Issue 3-4, 2009, Pages 185-192

  Manrique, Christine ^a   Compan, Valérie ^b   Rosselet, Céline ^a   Duflo, Sylvie Gustave Dit ^c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

Author keywords

GAD67; In vivo; Rat brain; siRNA; Striatum

Indexed keywords

GAD67; IN VIVO; RAT BRAIN; SIRNA; STRIATUM;

GENE EXPRESSION; MAMMALS; NUCLEIC ACIDS; RNA;

CELL CULTURE;

DOUBLE STRANDED RNA; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 67; ISOENZYME; MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CORPUS STRIATUM; DOWN-REGULATION; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, LONG-EVANS; RNA, MESSENGER; RNA, SMALL INTERFERING; SENSITIVITY AND SPECIFICITY;

MAMMALIA; RATTUS;

EID: 67650021224     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2009.05.009     Document Type: Article

References (55)

1. Aagaard L., and Rossi J.J. RNAi therapeutics: principles, prospects and challenges. Adv. Drug Deliv. Rev. 59 (2007) 75-86
2. Aigner A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J. Biotechnol. 124 (2006) 12-25
3. Aigner A. Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo. J. Biomed. Biotechnol. 2006 (2006) 71659
4. Bahi A., Boyer F., Bussard G., and Dreyer J.L. Silencing dopamine D3-receptors in the nucleus accumbens shell in vivo induces changes in cocaine-induced hyperlocomotion. Eur. J. Neurosci. 21 (2005) 3415-3426
5. Bird E.D., and Iversen L.L. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97 (1974) 457-472
6. Bosher J.M., and Labouesse M. RNA interference: genetic wand and genetic watchdog. Nat. Cell Biol. 2 (2000) E31-E36
7. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
8. Bu D., Erlander M.G., Hitz B.C., Tilakaratne N.J.K., Kaufman D.L., Wagner-McPherson C.B., Evans G.A., and Tobin A.J. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc. Natl. Acad. Sci. 89 (1992) 2115-2119
9. Caplen N.J., Parrish S., Imani F., Fire A., and Morgan R.A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. 98 (2001) 9742-9747
10. Ceranik K., Bender R., Geiger J.R., Monyer H., Jonas P., Frotscher M., and Lübke J. A novel type of GABAergic interneuron connecting the input and the output regions of the hippocampus. J. Neurosci. 17 (1997) 5380-5394
11. Chu C., Zhang Y., Boado R.J., and Pardridge W.M. Decline in exogenous gene expression in primate brain following intravenous administration is due to plasmid degradation. Pharm. Res. 23 (2006) 1586-1590
12. Conductier G., Dusticier N., Lucas G., Cote F., Debonnel G., Daszuta A., Dumuis A., Nieoullon A., Hen R., Bockaert J., and Compan V. Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse. Eur. J. Neurosci. 24 (2006) 1053-1062
13. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
14. Erlander M.G., and Tobin A.J. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem. Res. 16 (1991) 215-226
15. Esclapez M., Tillakaratne N.J.K., Tobin A.J., and Houser C.R. Comparative localization of mRNAs encoding two forms of glutamic acid decarboxylase with nonradioactive in situ hybridization methods. J. Comp. Neurol. 331 (1993) 339-362
16. Esclapez M., Tillakaratne N.J.K., Kaufman D.L., Tobin A.J., and Houser C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J. Neurosci. 14 (1994) 1834-1855
17. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello G.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
18. Fountaine T.M., Wood M.J., and Wade-Martins R. Delivering RNA interference to the mammalian brain. Curr. Gene Ther. 5 (2005) 399-410
19. Freichel C., Potschka H., Ebert U., Brandt C., and Löscher W. Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus. Neuroscience 141 (2006) 2177-2194
20. Glass M., Dragunow M., and Faull R.L. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 97 (2000) 505-519
21. Guissouma H., Clerget Froidevaux M.S., Hassani Z., and Demeneix B.A. In vivo siRNA delivery to the mouse hypothalamus confirms distinct roles of TR beta isoforms in regulating TRH transcription. Neurosci. Lett. 406 (2006) 240-243
22. Hassani Z., Lemkine G.F., Erbacher P., Palmier K., Alfama G., Giovannangeli C., Behr J.P., and Demeneix B.A. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels. J. Gene Med. 7 (2005) 198-207
23. Hassani Z., François J.C., Alfama G., Dubois G.M., Paris M., Giovannangeli C., and Demeneix B.A. A hybrid CMV-H1 construct improves efficiency of PEI-delivered shRNA in the mouse brain. Nucleic Acids Res. 35 (2007) E65
24. Hommel J.D., Sears R.M., Georgescu D., Simmons D.L., and DiLeone R.J. Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. 9 (2003) 1539-1544
25. Jacob F., and Monod J. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3 (1961) 318-356
26. Jean A., Conductier G., Manrique C., Berta P., Hen R., Charnay Y., Bouras C., Bockaert J., and Compan V. Appetite-suppressant effect of ecstasy: involvement of 5-HT4 receptor-dependent CART expression in the nucleus accumbens. Proc. Natl. Acad. Sci. 104 (2007) 16335-16340
27. Kaufman D.L., Houser C.R., and Tobin A.J. Two forms of the γ-Aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56 (1991) 720-723
28. Koch U., and Magnusson A.K. Unconventional GABA release: mechanisms and function. Curr. Opin. Neurobiol. (2009) (Ahead of print)
29. Leung R.K., and Whittaker P.A. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol. Ther. 107 (2005) 222-239
30. Lewis D.A., Hashimoto T., and Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6 (2005) 312-324
31. Liévens J.C., Dutertre M., Forni C., Salin P., and Kerkerian-Le Goff L. Continuous administration of the glutamate uptake inhibitor l-trans-pyrrolidine-2,4-dicarboxylate produces striatal lesion. Mol. Brain Res. 50 (1997) 181-189
32. Lindefors N. Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Prog. Neuropsychopharmacol. Biol. Psychiatry 17 (1993) 887-903
33. Liu J., Valencia-Sanchez M.A., Hannon G.J., and Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol. 7 (2005) 643-644
34. Makimura H., Mizuno T.M., Mastaitis J.W., Agami R., and Mobbs C.V. Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci. 3 (2002) 18
35. 1B binding sites with retinal and geniculate axon terminals in the rat suprachiasmatic nucleus. Synapse 33 (1999) 314-323
36. Martin D.L. Regulatory properties of brain glutamate decarboxylase. Cell. Mol. Neurobiol. 7 (1987) 237-253
37. Martin D.L., Martin S.B., Wu S.J., and Espina N. Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain. J. Neurosci. 11 (1991) 2725-2731
38. Mugnaini E., and Oertel W.H. An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Bjorklund A., and Hokfelt T. (Eds). Handbook of Chemical Neuroanatomy (1985), Elsevier, Amsterdam 436-622
39. Oliveira S., Storm G., and Schiffelers R.M. Targeted Delivery of siRNA. J. Biomed. Biotechnol. 2006 (2006) 63675
40. Pardridge W.M. ShRNA and siRNA delivery to the brain. Adv. Drug Deliv. Rev. 59 (2007) 141-152
41. Paul C.P., Good P.D., Winer I., and Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20 (2002) 505-508
42. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. third edition (1997), Academic Press, New York
43. Rosselet C., Zennou-Azogui Y., and Xerri C. Nursing-induced somatosensory cortex plasticity: temporally decoupled changes in neuronal receptive field properties are accompanied by modifications in activity-dependent protein expression. J. Neurosci. 26 (2006) 10667-10676
44. Salahpour A., Medvedev I.O., Beaulieu J.M., Gainetdinov R.R., and Caron M.G. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol. Psychiatry 61 (2007) 65-69
45. Senn C., Hangartner C., Moes S., Guerini D., and Hofbauer K.G. Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides. Eur. J. Pharmacol. 522 (2005) 30-37
46. Shi N., Zhang Y., Zhu C., Boado R.J., and Pardridge W.M. Brain-specific expression of an exogenous gene after i.v. administration. Proc. Natl. Acad. Sci. 98 (2001) 12754-12759
47. Shishkina G.T., Kalinina T.S., and Dygalo N.N. Attenuation of alpha2Adrenergic receptor expression in neonatal rat brain by RNA interference or antisense oligonucleotide reduced anxiety in adulthood. Neuroscience 129 (2004) 521-528
48. Thakker D.R., Natt F., Husken D., Maier R., Muller M., van der Putten H., Hoyer D., and Cryan J.F. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc. Natl. Acad. Sci. 101 (2004) 17270-17275
49. Thakker D.R., Natt F., Husken D., van der Putten H., Maier R., Hoyer D., and Cryan J.F. SiRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol. Psychiatry 10 (2005) 782-789
50. Wassef A., Baker J., and Kochan L. GABA and schizophrenia: a review of basic science and clinical studies. J. Clin. Psychopharmacol. 23 (2003) 601-640
51. Xia H., Mao Q., Paulson H.L., and Davidson B.L. SiRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20 (2002) 1006-1010
52. Zeringue H.C., and Constantine-Paton M. Post-transcriptional gene silencing in neurons. Curr. Opin. Neurobiol. 14 (2004) 654-659
53. Zhang Y., Calon F., Zhu C., Boado R.J., and Pardridge W.M. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. Hum. Gene Ther. 14 (2003) 1-12
54. Zhang Y., Schlachetzki F., Zhang Y.F., Boado R.J., and Pardridge W.M. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter. Hum. Gene Ther. 15 (2004) 339-350
55. Zhu C., Zhang Y., and Pardridge W.M. Widespread expression of an exogenous gene in the eye after intravenous administration. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3075-3080